Reading Hospital/McGlinn Cancer Institute — Wyomissing, Pennsylvania

Reading Hospital/McGlinn Cancer Institute is a clinical research site located in Wyomissing, Pennsylvania, United States 19610.

Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Reading Hospital/McGlinn Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer.

Sponsors: Alliance Foundation Trials, LLC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wyomissing

Browse all research sites in Pennsylvania · View every site in Wyomissing

• reading Hospital /ID# 223599
• Reading Hospital Study
• Clinical Research Center of Reading
• Research Site
• GSK Investigational Site
• Pfizer Investigational Site
• Berks Cardiologists, LTD
• Radiant Research
• Respiratory Specialists
• Clinical Research Center of Reading LLP
• Digestive Disease Associates

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Reading Hospital/McGlinn Cancer Institute?

Reading Hospital/McGlinn Cancer Institute has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Reading Hospital/McGlinn Cancer Institute conducted?

Reading Hospital/McGlinn Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Breast Cancer.

Is Reading Hospital/McGlinn Cancer Institute accredited by Crixeo Clinical Trials?

Reading Hospital/McGlinn Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Reading Hospital/McGlinn Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.